Long-acting muscarinic antagonist

This page covers all Long-acting muscarinic antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting M3 muscarinic receptor.

Targets

M3 muscarinic receptor

Phase 2 pipeline (1)

• CHF6001 DPI · Chiesi Farmaceutici S.p.A. · Respiratory
  CHF6001 DPI is a dry powder inhaler formulation of a long-acting muscarinic antagonist.